![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo.svg){kind=logo}
Advertisement
All
>
Persons > Northern Europe
Please find below persons from Denmark, Estonia, Finland, Iceland, Ireland, Latvia, Lithuania, Norway, Sweden and the UK as well as related to organisations from these countries.Total search results: 4158 | Ordered by Person (ascending)
1 2 3 ... 40 41 42 
  Person |
 Position |
Organisation (Group) |
Country |
|---|---|---|---|
| White, Amanda (Health Data Research UK 201807 Director of Communications + Marketing) | Public Relations Manager / Investor Relations Manager | Health Data Research UK | United Kingdom (GB) |
| White, Bryan | n. a. | ||
| White, Colin (Perceptive Instruments 201311 Managing Director) | Managing Director | Instem (Group) | United Kingdom (GB) |
| White, James (Osmetech 200511 CEO) | Chief Executive Officer (CEO) | Roche (Group) | United Kingdom (GB) |
| Whitehead, Carlene (Danaher 201204 European MarCom Specialist at Molecular Devices UK) | Public Relations Manager / Investor Relations Manager | Danaher (Group) | United Kingdom (GB) |
| Whitehead, Stephen (ABPI 201211 Chief Executive) | Chief Executive Officer (CEO) | ABPI (Association of the British Pharmaceutical Industry) | United Kingdom (GB) |
| Whitehurst, Peter (Arcis:Altos 201810 CEO of Arcis Biotechnology) | Chief Executive Officer (CEO) | Arcis:Altos (Group) | United Kingdom (GB) |
| Whiteley, Nick (European Spectrometry Systems founder) | Company Founder | European Spectrometry Systems Ltd. (ESS) | United Kingdom (GB) |
| Whitmore, Terry (Henniker Scientific 200901– founder) | Company Founder | Henniker Scientific Ltd. | United Kingdom (GB) |
| Whittingham, Jerel (Myconostica 200804 CEO) | Chief Executive Officer (CEO) | Novacyt (Group) | United Kingdom (GB) |
| Whittley, Nadia (Arquer Diagnostics 201612– CEO before Tefen Management Consulting + Alium Medical + Allergan) | Chief Executive Officer (CEO) | Arquer Diagnostics Ltd. | United Kingdom (GB) |
| Whyatt, Fiona (Ramarketing 202211) | Public Relations Manager / Investor Relations Manager | Ramarketing (Group) | United Kingdom (GB) |
| Wickholm, Håkan (Lytix Biopharma AS 201603– CEO) | Chief Executive Officer (CEO) | Lytix Biopharma AS | Norway |
| Wicks, Jim (PrimerDesign Ltd 201201 Managing Director) | Managing Director | Novacyt (Group) | United Kingdom (GB) |
| Widdowson, Caroline (Schauenburg 201412 promoted Produt Marketing Manager Thermal Desorption at Markes) | Sales Manager / Marketing Manager | Schauenburg (Group) | United Kingdom (GB) |
| Widdowson, Peter S. (Quethera 201808 CEO) | Chief Executive Officer (CEO) | Astellas (Group) | United Kingdom (GB) |
| Widell, Mikael (Pharmalink AB 201708– Head of Communications before Cord Communications + Nordic Capital) | Public Relations Manager / Investor Relations Manager | Calliditas Therapeutics (Group) | Sweden |
| Widstrand, Christine (MIP Technologies 200801 CEO + VP Sales + Marketing + Founder) | Sales Manager / Marketing Manager | Biotage (Group) | Sweden |
| Wiederhold, Bob (Synthace 202105 Board Chairman) | Board member, non-executive | Synthace (Group) | United Kingdom (GB) |
| Wiener, Albrecht (Eppendorf UK 200704 Managing Director) | Managing Director | Eppendorf (Group) | United Kingdom (GB) |
| Wihlborg, Anna-Karin (Biotage 201101 Product Manager SPE) | Product Manager (personnel) | Biotage (Group) | Sweden |
| Wiinberg, Ulf (Lundbeck 200806–201411 CEO before Wyeth RESIGNED 11/14) | Chief Executive Officer (CEO) | Lundbeck (Group) | Denmark |
| Wiklund, Erik Digman (Targovax 202110– CEO before CBO + CFO joined 4/17 before Aker Biomarine + McKinsey) | Chief Executive Officer (CEO) | Circio (Group) | Norway |
| Wiklund, Jesper P. (Index Pharmaceuticals 201109– CEO before Sobi before Affectis + Evotec OAI + DeveloGen + Elan) | Chief Executive Officer (CEO) | InDex Pharmaceuticals (Group) | Sweden |
| Wilcock, Iain (200811– BPCE Investment Advisor to Seventure Partners + Vela Ventures before Quester) | n. a. | BPCE (Group) | France |
| Wilcockson, Mark (United Kingdom (govt) 202210 at British Business Bank) | Investment Manager | Mercia (Group) | United Kingdom (GB) |
| Wilde, Lars Christian (Compass Pathways 202004 CBO + Co-Founder) | Chief Business Officer (CBO) | Compass Pathways (Group) | United Kingdom (GB) |
| Wiley, Joseph (Joe) (Amryt Pharma 201912 CEO) | Chief Executive Officer (CEO) | Amryt Pharma (Group) | Ireland, Republic of |
| Wilhelmsson, Claes | Investment Manager | Investor AB (Wallenberg) (Group) | Sweden |
| Wilkie, James (Univ Birmingham 201410 CEO of Alta Innovations) | Chief Executive Officer (CEO) | University of Birmingham | United Kingdom (GB) |
| Wilkinson, Malcolm (Kirkstall 201802 CEO) | Chief Executive Officer (CEO) | Kirkstall (GB) | United Kingdom (GB) |
| Willcocks, Spike (Oxford NanoLabs 200702 Director of Business Development) | Business Development Manager / Strategy Manager | Oxford Nanopore (Group) | United Kingdom (GB) |
| Willetts, David (United Kingdom (govt) 201205 Minister for Universities and Science) | Minister | United Kingdom (GB) (govt) | United Kingdom (GB) |
| Williams, Andrew (Halma 201011 CEO) | Chief Executive Officer (CEO) | Halma (Group) | United Kingdom (GB) |
| Williams, Andrew (LabLogic Systems 200801– before Leeds University) | Sales Manager / Marketing Manager | LabLogic (Group) | United Kingdom (GB) |
| Williams, Antony (RSC 200905– VP Strategic Development before ChemZoo 200804 President) | n. a. | Royal Society of Chemistry, The (RSC) | United Kingdom (GB) |
| Williams, David (Nanna Therapeutics 202004 CEO before Discuva) | Chief Executive Officer (CEO) | Astellas (Group) | United Kingdom (GB) |
| Williams, Doris-Ann (BIVDA 200705 Director General) | General Manager (management) | BIVDA (British In Vitro Diagnostic Regulatory Association) | United Kingdom (GB) |
| Williams, Jon (Aquapharm Biodiscovery 201207 VP Commercial) | Chief Commercial Officer (CCO) | Aquapharm Biodiscovery Ltd. | United Kingdom (GB) |
| Williams, Nick (Medicxi 202206) | n. a. | Medicxi Ventures (formerly Index Ventures Life Sciences) | United Kingdom (GB) |
| Williams, Richard (AstraZeneca 200707 CIO) | n. a. | AstraZeneca (Group) | United Kingdom (GB) |
| Williams, Sam (IP Group 201411 CEO of Modern Biosciences plc) | Chief Executive Officer (CEO) | IP Group (Group) | United Kingdom (GB) |
| Williamson, Alison (BioCaptiva 202204– CFO before Dysis Medical + Aircraft Medical + Deloitte + RMD + KPMG) | Chief Financial Officer (CFO) | BioCaptiva Ltd. | United Kingdom (GB) |
| Williamson, Andrew (Cambridge Innovation Capital 201906 Managing Partner) | Managing Partner (investment firm) | Cambridge Innovation Capital (Group) | United Kingdom (GB) |
| Williamson, Anna (Roche 202106 Executive Director Business Development + Head UK BusDev at Roche/Genentech) | Business Development Manager / Strategy Manager | Roche (Group) | Switzerland |
| Williamson, David (Nova Capital Management 200710 Managing Director) | Managing Director | Nova Capital (Group) | United Kingdom (GB) |
| Williamson, Jerry (Genetix 200801– President US Operations) | n. a. | Danaher (Group) | United Kingdom (GB) |
| Willingham, Finn (Angel Biotechnology 200602) | n. a. | Angel Biotechnology (Group) | United Kingdom (GB) |
| Wilson, Dominic (Bryan Garnier 201709– Managing Director at European Healthcare division before Zeus Capital + Nomura) | Managing Director | Bryan, Garnier & Co., Ltd. | United Kingdom (GB) |
| Wilson, Edmund (Titian Software 201206 CEO) | Chief Executive Officer (CEO) | Titian Software (Group) | United Kingdom (GB) |
| Wilson, Genevieve (Consilium Strategic Communications 202109) | Public Relations Manager / Investor Relations Manager | ICR (Group) | United Kingdom (GB) |
| Wilson, Ian (ImaginAb 201902– CEO joined 201802 as COO before Edinburgh Molecular Imaging + Xstrahl Ltd) | Chief Executive Officer (CEO) | ImaginAb Inc. | United States (USA) |
| Wilson, Ian (Imperial College London 201208– Professor before AstraZeneca Senior Principle Scientist) | Professor | Imperial College London | United Kingdom (GB) |
| Wilson, Julia (Achilles Therapeutics 202011 Head of Communications + JW Communications 201209– before Vectura Group) | Public Relations Manager / Investor Relations Manager | JW Communications Ltd. | United Kingdom (GB) |
| Wilson, Keith (Oxford BioTherapeutics 201506 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Oxford BioTherapeutics Ltd. (OBT) | United Kingdom (GB) |
| Wilson, Peter (CellaVision 201209– promoted President North America before Marketing Manager) | President/Director/Head Business Group/Unit/Division | CellaVision (Group) | Sweden |
| Wilson, Rod (Peak Scientific 201606 Senior South East Asia Territory Manager) | Regional manager | Peak Scientific (Group) | United Kingdom (GB) |
| Wilson, Sarah (Consilium Strategic Communications 201903) | Public Relations Manager / Investor Relations Manager | ICR (Group) | United Kingdom (GB) |
| Wilson, Tim (Igem Therapeutics 201804 CEO) | Chief Executive Officer (CEO) | Igem Therapeutics Ltd. | United Kingdom (GB) |
| Wilson, Tom (Seedcamp 202402 Partner) | Partner (venture partner) | Seedcamp (GB) | United Kingdom (GB) |
| Wilson, Vicki (DxS 200808– Diagnostics Product Manager before Invitrogen + Bayer Diagnostics + Tecan + Dade Behring) | Product Manager (personnel) | Qiagen (Group) | United Kingdom (GB) |
| Winder, Rob (FTI Consulting 201412) | Public Relations Manager / Investor Relations Manager | FTI Consulting (Group) | United Kingdom (GB) |
| Winge, Mårten (Strike Pharma 202104– CEO before Cartana + Pyrosequencing + Olink + Halo genomics + Doxa + Proxeon) | Chief Executive Officer (CEO) | Strike Pharma AB | Sweden |
| Winkler, Frank (Univ Heidelberg + DKFZ 201909 Professor + Co-Founder of Divide & Conquer) | Professor | University of Heidelberg (Ruperto Carola) | |
| Winroth, Jörgen (Swedish Orphan Biovitrum 201512 VP + Head of Investor Relations) | Public Relations Manager / Investor Relations Manager | Swedish Orphan Biovitrum (Sobi) (Group) | Sweden |
| Winter, Gregory (MRC + CAT + Domantis + Nobel Laureate) | Professor | United Kingdom (GB) (govt) | United Kingdom (GB) |
| Winterhalter, Karen (Onyx Health PR 201808 Managing Director + Founder) | Public Relations Manager / Investor Relations Manager | Onyx Health Ltd. (Onyx Health PR) | United Kingdom (GB) |
| Wintero, Trine | Chief Operating Officer (COO) | Symbion Capital | Denmark |
| Winther, Erik (DakoCytomation 200506 Executive VP + CFO) | Chief Financial Officer (CFO) | Agilent (Group) | Denmark |
| Wise, Alan (IOmet Pharma 201601 CEO) | Chief Executive Officer (CEO) | Merck (US) (MSD) (Group) | United Kingdom (GB) |
| Wise, James (Balderton Capital 202204 Partner) | Partner (venture partner) | Balderton Capital (UK) LLP | United Kingdom (GB) |
| Withey, Fiona (TrakCel 202002– CEO + Co-Founder before PCI Pharma Services + Biotec Services International) | Chief Executive Officer (CEO) | TrakCel (Group) | United Kingdom (GB) |
| Wittendorff, Jørgen (Silence Therapeutics 201908– Head of Manufacturing before Ablyn + Ferring + Novo Nordisk) | Production Manager | Silence Therapeutics (Group) | United Kingdom (GB) |
| Witty, Andrew (Hatteras Venture Partners 201709– Venture Partner former GSK CEO 2008–2017 joined 1985) | Partner (venture partner) | Hatteras Venture Partners (HVP) | United States (USA) |
| Witz, Pascale (Sanofi 201307–201605 EVP before GE Healthcare + Becton Dickinson LEFT 6/16) | President/Director/Head Business Group/Unit/Division | Sanofi (Group) [since May 2011] | France |
| Wlodek, Aleksandra M. (Ola) (Constructive Biology 202207– CEO before Reflection Therapeutics) | Chief Executive Officer (CEO) | Constructive Biology Ltd. (Constructive Bio) | United Kingdom (GB) |
| Wolf, Stefan (Binding Site 202210 CEO before Thermo Fisher + Siemens + Dade Behring) | Chief Executive Officer (CEO) | Thermo Fisher (Group) | United Kingdom (GB) |
| Wolf-Ahrens, Patricia (LifeScience Connect 202309) | n. a. | LifeScience Connect Ltd. (LifeScience ORG) | United Kingdom (GB) |
| Wolff, Marianne (Cobra Biologics 201511 Marketing) | Sales Manager / Marketing Manager | Charles River (Group) | Sweden |
| Wolfson, Andrew (Pembroke 202302 CEO of Pembroke Investment Managers) | Chief Executive Officer (CEO) | Pembroke (Group) | United Kingdom (GB) |
| Wollman, Lilly (Generation Investment Management 201901 Co-Head Growth Equity Team) | Investment Manager | Generation Investment Management LLP | United Kingdom (GB) |
| Wolstenholme, Rosalind (Sheffiel Hallam Univ 201107 Researcher at BMRC) | Researcher (university / research institute) | Sheffield Hallam University | United Kingdom (GB) |
| Wong, James (Univ Oxford 202102 Principal at Oxford Sciences Innovation) | Principal (venture capital) | Oxford Science Enterprises (Group) | United Kingdom (GB) |
| Wood, Christopher B. (Chris) (NuCana Biomed 2008– Executive Chair + Co-founder before Bioenvision 1999–2007 CEO) | Chief Executive Officer (CEO) | NuCana plc (Nasdaq: NCNA) | United Kingdom (GB) |
| Wood, Fleur (BenevolentAI 202309 VP Investor Relations) | Public Relations Manager / Investor Relations Manager | BenevolentAI (Group) | United Kingdom (GB) |
| Wood, James (Edinburgh BioQuarter 201110 Head of Communications and Media) | Public Relations Manager / Investor Relations Manager | Edinburgh BioQuarter | United Kingdom (GB) |
| Wood, Tony (GSK 202210 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | GSK (Group) | United Kingdom (GB) |
| Woodford, Neil (Woodford Investment) | Investment Manager | Woodford Investment (Group) | United Kingdom (GB) |
| Woodhouse, Rory (Oxford Expression Technologies 201303 Sales Manager) | Sales Manager / Marketing Manager | Oxford Expression Technologies Ltd. (OET) | United Kingdom (GB) |
| Woodlock, Don (GE Healthcare 200710 VP + global general manager Imaging Solutions) | General Manager (management) | General Electric (Group) | United Kingdom (GB) |
| Woodrow, Gordon (Proteros Biostructures 201008 EVP Strategic Alliances) | Business Development Manager / Strategy Manager | Proteros (Group) | United Kingdom (GB) |
| Woodruff, Mark (Fortis Technologies 201405 Sales + Marketing Director) | Sales Manager / Marketing Manager | Fortis Technologies Ltd. | United Kingdom (GB) |
| Woodward, Alan (Simbec Research 201305 Business Development Manager) | Business Development Manager / Strategy Manager | Simbec Research Ltd. | United Kingdom (GB) |
| Woolf, Nick (Oxford Biomedica 200201– CBO before ABN AMRO) | Chief Business Officer (CBO) | Oxford Biomedica (Group) | United Kingdom (GB) |
| Woolfenden, Elizabeth (Liz) (Markes 200902 Director) | President/Director/Head Business Group/Unit/Division | Schauenburg (Group) | United Kingdom (GB) |
| Woolfson, Dek (Univ Bristol 201401 Prof School of Chemistry + Biochemistry + Director of BrisSynBio Centre) | Professor | University of Bristol, BrisSynBio Centre | United Kingdom (GB) |
| Worswick, Richard (LGC 200001) | n. a. | LGC (Group) | United Kingdom (GB) |
| Wray, Jonny (e-Therapeutics 201801 Head of Discovery Informatics) | n. a. | e-Therapeutics plc (AIM: ETX) | United Kingdom (GB) |
| Wright, Chris (Molecular Vision 200705 Executive Chairman) | President/Director/Head Business Group/Unit/Division | Molecular Vision Ltd. | United Kingdom (GB) |
| Wright, Moray (Parkwalk Advisors 201803 CEO) | Chief Executive Officer (CEO) | IP Group (Group) | United Kingdom (GB) |
1 2 3 ... 40 41 42
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
